Haemato AG (HAEK) — Capital Reinvestment Ratio
Haemato AG (HAEK) has a Capital Reinvestment Ratio of 0.06x as of December 2022, meaning it reinvests 0% of its operating cash flow (€19.73 Million) in capital expenditures (€1.09 Million). Check tangible equity quality of Haemato AG to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Haemato AG Capital Reinvestment Ratio (2021–2022)
This chart tracks Haemato AG's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Haemato AG cash conversion from operations.
Annual Capital Reinvestment Ratio for Haemato AG (2021–2022)
Year-by-year Capital Reinvestment Ratio for Haemato AG from 2021 to 2022. See HAEK cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | €19.73 Million | €1.09 Million | ▲ +137.4% |
| 2021 | 0.02x | €14.05 Million | €326.75K | — |